The antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir, affect inflammation and insulin sensitivity in human coronary endothelial cells through different pathways. The antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir, affect inflammation and insulin sensitivity in human coronary endothelial cells through different pathways
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
The antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir, affect inflammation and insulin sensitivity in human coronary endothelial cells through different pathways. Overall design: Human coronary endothelial cells treated with the antiretroviral drugs dolutegravir, maraviroc and ritonavir-boosted atazanavir.
创建时间：
2019-09-10
相关数据集
暂无相关数据集
